Research- In order to lay the foundation for hanging network tender.docVIP

 PAGE \* MERGEFORMAT 4 Research: In order to lay the foundation for hanging network tender Any in the hanging nets are not far-fetched, is summing up the experience and the pre-tender on the basis of the characteristics of this region carried out. Thus, pharmaceutical companies must be pre-linked network of the land seriously the previous tender or hanging nets for analysis, do a thorough and comprehensive research strategy for the development of hanging nets lay a solid foundation. First, the pharmaceutical companies to tender in accordance with the company’s internal control system, hanging the net the next 3 months to send someone to intervene will be carried out by hanging net, through the center of government procurement, tendering an intermediary, influential experts visit to understand The next time hanging net policy changes that may occur through the above-mentioned departments and personnel in contact with the enterprise network of hanging the observations and recommendations, as well as the special situation of enterprises to effectively reflect the order in policy-making departments and experts on the tender consideration. Second, be familiar with the last hanging network models and procedures. Companies entering the market for the first time, research must be targeted by similar products, competitive products in the network status of the last hanging in-depth analysis, development strategy for hanging net; for hanging net again in the enterprise, to sum up and analyze The last hanging network problems, to avoid the same mistakes. Third, the concern about the dynamics and the process of tendering. Under normal circumstances, through the competent departments and experts hanging nets to make the visit, you can learn relevant information, such as hanging the net price of the real situation of government departments, the original database information adjustments and amendments to demonstrate the convening of the meeting, also can be pharmaceutical c